Research Paper Volume 13, Issue 8 pp 12099—12112

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer

The relationships between the immune-based prognostic index and clinicopathological factors. (A) age; (B) gender; (C) pathological stage; (D) T stage; (E) N stage and (F) M stage in the high-risk (red) and low-risk (blue) groups of the BLCA.

Figure 7. The relationships between the immune-based prognostic index and clinicopathological factors. (A) age; (B) gender; (C) pathological stage; (D) T stage; (E) N stage and (F) M stage in the high-risk (red) and low-risk (blue) groups of the BLCA.